shot-button
Ganesh Chaturthi Ganesh Chaturthi
Home > News > World News > Article > Covid 19 sub variant in US results in 80 per cent new cases

Covid-19 sub-variant in US results in 80 per cent new cases

Updated on: 31 July,2022 08:10 AM IST  |  Washington
Agencies |

The sub-variant accounted for 81.9 per cent of the new infections in the week ending July 23

Covid-19 sub-variant in US results in 80 per cent new cases

Representative Image

The BA.5 Omicron sub-variant, now the dominant Coronavirus strain in the US, accounts for over 80 per cent of the new cases in the country, according to the latest data from the Centres for Disease Control and Prevention (CDC).


The sub-variant accounted for 81.9 per cent of the new infections in the week ending July 23. Another new sub-variant, BA.4, accounted for 12.9 per cent of new infections, CDC data showed. The two contagious sub-variants now make up over 90 per cent of new infections in the US.


Also Read: Back to being Doctor Sahiba


2,37,56,368
Total number of active cases Worldwide as of Saturday

64,18,043
Total no of deaths worldwide

55,10,08,227
Patients recovered worldwide as of Saturday

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK